NCT02276027
- Conditions
- Adenocarcinoma, Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma, Adenocarcinoma of Lung, +8 more
- Locations
-
- Novartis Investigative Site Guangzhou, Guangdong, China
Clinical trial condition
Explore clinical trials studying Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.
NCT02276027